Skip to main content

Table 4 Clinical data in 145 patients who developed thrombocytopenia

From: Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome

Variable Value
Development of thrombocytopenia  
  At the time of ICU admit, n (%) 77 (25.3)
  During the ICU/hospital course, n (%) 68 (22.3)
Duration of thrombocytopenia (days), median (IQR) 4.4 (1.9–6.9)
Resolution of thrombocytopenia by hospital discharge, n (%) 86 (59.3)
Severity of thrombocytopenia  
  Mild, n (%) 72 (49.6)
  Moderate, n (%) 47 (32.4)
  Severe, n (%) 19 (13.1)
  Very severe, n (%) 7 (4.8)
Disseminated intravascular coagulation, n (%) 37 (25.5)
Drug-induced thrombocytopenia, n (%) 26 (17.9)
Heparin-induced thrombocytopenia, n (%) 1 (0.6)
  1. ICU, intensive care unit; IQR, interquartile range.